The AD risk-associated MEF2C transcription factor, as well as MAFG, JUND, CEBPB, MAF, and LHX2 were up-regulated, suggesting roles for these transcription factors in the regulation of responses to AD pathology. This evidence concerns the gene MAFG and Alzheimer disease.